DK0858807T3 - Anvendelse af dopaminreceptor-antagonister i palliativ tumorterapi - Google Patents

Anvendelse af dopaminreceptor-antagonister i palliativ tumorterapi

Info

Publication number
DK0858807T3
DK0858807T3 DK97121009T DK97121009T DK0858807T3 DK 0858807 T3 DK0858807 T3 DK 0858807T3 DK 97121009 T DK97121009 T DK 97121009T DK 97121009 T DK97121009 T DK 97121009T DK 0858807 T3 DK0858807 T3 DK 0858807T3
Authority
DK
Denmark
Prior art keywords
receptor antagonists
dopamine receptor
tumor therapy
palliative
palliative tumor
Prior art date
Application number
DK97121009T
Other languages
English (en)
Inventor
Bernd Nickel
Thomas Klenner
Peter Hilgard
Juergen Engel
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Application granted granted Critical
Publication of DK0858807T3 publication Critical patent/DK0858807T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
DK97121009T 1996-12-06 1997-11-29 Anvendelse af dopaminreceptor-antagonister i palliativ tumorterapi DK0858807T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19650778A DE19650778C2 (de) 1996-12-06 1996-12-06 Verwendung von Dopaminrezeptor-Antagonisten in der palliativen Tumortherapie
EP97121009A EP0858807B1 (de) 1996-12-06 1997-11-29 Verwendung von Dopaminrezeptor-Antagonisten in der palliativen Tumortherapie

Publications (1)

Publication Number Publication Date
DK0858807T3 true DK0858807T3 (da) 2000-07-31

Family

ID=7813911

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97121009T DK0858807T3 (da) 1996-12-06 1997-11-29 Anvendelse af dopaminreceptor-antagonister i palliativ tumorterapi

Country Status (11)

Country Link
US (3) US6093704A (da)
EP (1) EP0858807B1 (da)
JP (1) JPH10167969A (da)
AT (1) ATE192044T1 (da)
BR (1) BR9706229A (da)
CA (1) CA2223469C (da)
DE (2) DE19650778C2 (da)
DK (1) DK0858807T3 (da)
ES (1) ES2146063T3 (da)
GR (1) GR3033768T3 (da)
PT (1) PT858807E (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8383605B2 (en) * 2002-07-30 2013-02-26 Aeterna Zentaris Gmbh Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals
KR20130016413A (ko) * 2002-07-30 2013-02-14 아에테르나 젠타리스 게엠베하 항종양 약제와 조합하여 사용하기 위한 알킬포스포콜린의 약물 제품
AR058397A1 (es) 2005-12-19 2008-01-30 Zentaris Gmbh Derivados de alquilfosfolipidos con citotoxicidad reducida y usos de los mismos
WO2009148623A2 (en) 2008-06-05 2009-12-10 Stc.Unm Methods and related compositions for the treatment of cancer
CA2794513A1 (en) 2010-03-31 2011-10-06 Aeterna Zentaris Gmbh Perifosine and capecitabine as a combined treatment for cancer
KR102500766B1 (ko) 2017-12-29 2023-02-17 삼성전자주식회사 생체 신호 측정 장치 및 그의 동작 방법
KR102203334B1 (ko) * 2019-04-12 2021-01-15 성균관대학교산학협력단 피모자이드의 항암제 병용요법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707484A (en) * 1986-11-25 1987-11-17 Hoffmann-La Roche Inc. Substituted piperidinomethylindolone and cyclopent(b)indolone derivatives
JPS6483016A (en) * 1987-09-25 1989-03-28 Arakawa Chem Ind Regulator for motile function of gastrointestinal tract
EP0855397B1 (en) * 1995-07-28 2001-05-09 Dainippon Pharmaceutical Co., Ltd. (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridine-carboxamide, process for producing the same and medicinal composition containing the same

Also Published As

Publication number Publication date
ES2146063T3 (es) 2000-07-16
JPH10167969A (ja) 1998-06-23
EP0858807B1 (de) 2000-04-26
CA2223469A1 (en) 1998-06-06
ATE192044T1 (de) 2000-05-15
US6093704A (en) 2000-07-25
DE59701508D1 (de) 2000-05-31
EP0858807A2 (de) 1998-08-19
US6696428B2 (en) 2004-02-24
CA2223469C (en) 2005-08-23
EP0858807A3 (de) 1999-03-24
PT858807E (pt) 2000-09-29
US20030008846A1 (en) 2003-01-09
BR9706229A (pt) 1999-05-04
US6576624B1 (en) 2003-06-10
DE19650778C2 (de) 2001-01-04
GR3033768T3 (en) 2000-10-31
DE19650778A1 (de) 1998-06-10

Similar Documents

Publication Publication Date Title
IL267381A (en) A pharmaceutical preparation containing dextromethorphan and quinidine for the treatment of nervous disorders
PT1135153E (pt) Utilizacoes para antagonistas e agonistas de receptores eph para tratar desordens vasculares
ATE295730T1 (de) Prävention und behandlung von auf ischämie- reperfusion und auf endotoxine zurückzuführende schäden unter verwendung von adenosin- und purin- rezeptor-antagonisten
FI953748A (fi) Yhdisteitä, joilla on sekä voimakas kalsium antagonisti- että antioksidanttiaktiivisuus sekä niiden käyttö solua suojaavina aineina
ATE446751T1 (de) Verwendung von methylnaltrexon zur behandlung von immunsuppression
MXPA05010819A (es) Uso de antagonistas de opioide perifericos, especialmente metilnaltrexona para tratar sindrome de intestino irritable.
DE69519672D1 (de) Synergistische tensidzusammensetzungen und konzentrate davon zur feuerbekämpfung
MY110217A (en) Use of l-deprenyl for retarding deterioration due to aging in dogs
DE69914357D1 (de) Pyridin-4-yl oder pyrimidin-4-yl substituierte pyrazine
ATE287267T1 (de) Kombinationstherapien mit gefässschädigender aktivität
DK0858807T3 (da) Anvendelse af dopaminreceptor-antagonister i palliativ tumorterapi
TR199900951T2 (xx) G���s kanserinin engellenmesi i�in y�ntemler.
DK1272897T3 (da) Adenosin-A2A-receptorantagonister til behandling og forebyggelse af leverfibrose, cirrose og fedtlever
IL132853A0 (en) Combination therapy for modulating the human sexual response
BR9708525A (pt) Método de tratamento de insuficência cardíaca com antagonistas de endotelina
ES2181915T3 (es) Ctla-8 en combinacionpn con g-csf y il-6, y uso de ctla-8 para tratar infecciones.
ZA988009B (en) Methods of administering an ampa receptor antagonist to treat dyskinesias associated with dopamine agonist therapy.
IT1205431B (it) Dispositivo di polarizzazione e compensazione per il potenziale elettrico nel corpo umano
ES1034645U (es) Protector bucodental antirradiaciones.
IT1243370B (it) Struttura per componente di mobile del tipo imbottito e rivestito
ATA23376A (de) Verfahren zum nachtraglichen einbau von sperrschichten in mauerwerk gegen aufsteigende feuchtigkeit und platte zur durchfuhrung des verfahrens
ATE116962T1 (de) Mentholderivate mit spasmolytik aktivität.
SE9604163D0 (sv) Låsbar låda i bak på sparken
IT8035702V0 (it) Accessorio pluriusi, particolarmente adatto nei locali igienici